Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Determining the Prognosis of Bell's Palsy Based on Severity at Presentation and Electroneuronography.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2021

Same author

Ulnar neuropathy at the elbow: Five new things.

Neurology. Clinical practice·2018

Same author

Selective Triceps Muscle Weakness in Myasthenia Gravis is Under-Recognized.

Journal of clinical neuromuscular disease·2016

Same author

Inter-rater reliability determination for two tests of ulnar nerve conduction across the elbow.

Muscle & nerve·2016

Same author

Ulnar nerve subluxation.

Muscle & nerve·2013

Same author

Genetic polymorphisms associated with exertional rhabdomyolysis.

European journal of applied physiology·2013

Search research articles

Related Experiment Videos

Statin myopathy.

Kristofer A Radcliffe¹, William W Campbell

¹Department of Neurology, Martin Army Community Hospital, 7950 Martin Loop, Fort Benning, GA 31905-5637, USA. kristofer.a.radcliffe@us.army.mil

Current Neurology and Neuroscience Reports

|March 28, 2008

Summary

This summary is machine-generated.

Statins can cause various muscle problems, from mild pain to severe rhabdomyolysis. Early recognition and management of statin myotoxicity are crucial to prevent serious complications.

Related Experiment Videos

Area of Science:

Pharmacology
Toxicology
Neurology

Background:

Medications are a common cause of toxic myopathy.
Statins are frequently implicated in drug-induced muscle damage.
Statin myotoxicity presents a spectrum of clinical manifestations.

Purpose of the Study:

To review the mechanisms of statin-induced myotoxicity.
To identify risk factors associated with statin myopathy.
To outline the evaluation and treatment strategies for statin myotoxicity.

Main Methods:

Literature review of statin myotoxicity.
Analysis of clinical presentations and outcomes.
Synthesis of current understanding of mechanisms and risk factors.

Main Results:

Statin myotoxicity ranges from myalgia to rhabdomyolysis.
Autoimmune myopathy is a potential adverse effect of statins.
Concomitant medications, medical conditions, and genetics are risk factors.

Conclusions:

Statin myotoxicity requires careful monitoring and prompt management.
Understanding risk factors can aid in prevention and early diagnosis.
Further research into mechanisms is needed to refine treatment approaches.